Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
University of Kentucky
Formycon AG
Vanderbilt-Ingram Cancer Center
Inhibrx Biosciences, Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Alliance Foundation Trials, LLC.
Pfizer